ENHANCE News
Most Popular ENHANCE Story
Merck, Schering's Vytorin fails trial
The gig is up, the news is out. Merck and Schering-Plough announced the results of its big ENHANCE trial this morning. And, as observers had begun to suspect, the study showed that, when it comes to... Read more...
Latest Headlines
- June 20, 2008
- March 24, 2008
- January 15, 2008
- January 14, 2008
- January 4, 2008
- December 18, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
